Title : Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer.

Pub. Date : 2015 May 8

PMID : 25953027






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Interestingly, the administration of sorafenib increased the expression levels of the androgen receptor, p-GSK3beta and p-ERK1/2 in castration-resistant prostate cancers. Sorafenib androgen receptor Mus musculus